Acalabrutinib is a selective second-generation Brutons tyrosine kinase (BTK) inhibitor, which prevents the activation of the B-cell antigen receptor (BCR) signaling pathway.
仅供研究使用。 我们不向患者出售。
化学信息
| 名称 | ACP-196 |
| Iupac 化学名称 | ACP-196 |
| 同义词 | Acalabrutinib |
| 英文同义词 | Acalabrutinib |
| 分子式 | C26H23N7O2 |
| 分子量 | 465.51 |
| InChiKey | |
| InChi | |
| Cas号 | 1420477-60-6 |
| 相关CAS号 | |
| 外观性状 | crystalline solid |
| 纯度 | 98% |
| 存储 | 3 years -20ºCpowder |
| 可溶性 | Soluble in DMSO |
| 处理方式 | |
| 运输条件 | Shipped under ambient temperature as non-hazardous chemical. |
| 海关编码 | |
| Targets | |
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study | |